XML 27 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION
3 Months Ended
Aug. 31, 2018
Equity [Abstract]  
11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION

11. STOCKHOLDERS’ EQUITY, COMPREHENSIVE INCOME AND STOCK-BASED COMPENSATION

 

    ACCUMULATED OTHER COMPREHENSIVE INCOME

 

    Changes in the components of AOCI, net of tax, were as follows (in thousands):

 

    Cumulative
Translation
Adjustments
    Unrealized Loss on Investments, Net     Total  
                   
Balance at May 31, 2018   $ 2,292     $ --     $ 2,292  
Other comprehensive (loss) income before reclassifications     (16 )     --       (16 )
Amounts reclassified out of AOCI     --       --       --  
Other comprehensive (loss) income, net of tax     (16 )     --       (16 )
Balance at August 31, 2018   $ 2,276     $ --     $ 2,276  

 

    STOCK-BASED COMPENSATION

 

    Stock-based compensation expense consists of expenses for stock options, restricted stock units, or RSUs, and employee stock purchase plan, or ESPP, purchase rights. Stock-based compensation expense for stock options and ESPP purchase rights is measured at each grant date, based on the fair value of the award using the Black-Scholes option valuation model, and is recognized as expense over the employee’s requisite service period. This model was developed for use in estimating the value of publicly traded options that have no vesting restrictions and are fully transferable. The Company’s employee stock options have characteristics significantly different from those of publicly traded options. For RSUs, stock-based compensation cost is based on the fair value of the Company’s common stock at the grant date. All of the Company’s stock-based compensation is accounted for as an equity instrument. See Note 10 in the Company’s Annual Report on Form 10-K for fiscal 2018 filed on August 28, 2018 for further information regarding the 2016 Equity Incentive Plan and the Amended and Restated 2006 ESPP.

 

    The following table summarizes the stock-based compensation expense for the three months ended August 31, 2018 and 2017 (in thousands):

 

    Three Months Ended  
    August 31,  
    2018     2017  
Stock-based compensation in the form of employee stock options, RSUs and ESPP purchase rights, included in:            
Cost of sales   $ 36     $ 22  
Selling, general and administrative     148       150  
Research and development     72       44  
Net effect on net (loss) income   $ 256     $ 216  

 

    As of August 31, 2018 and 2017, there were no stock-based compensation expenses capitalized as part of inventory.

 

    During the three months ended August 31, 2018 and 2017, the Company recorded stock-based compensation expenses related to stock options and RSUs of $173,000 and $201,000, respectively.

 

    As of August 31, 2018, the total compensation expense related to unvested stock-based awards under the Company’s 2016 Equity Incentive Plan, but not yet recognized, was approximately $1,449,000, which is net of estimated forfeitures of $4,000. This expense will be amortized on a straight-line basis over a weighted average period of approximately 3.2 years.

 

    During the three months ended August 31, 2018 and 2017, the Company recorded stock-based compensation expense related to the ESPP of $83,000 and $15,000, respectively.

 

    As of August 31, 2018, the total compensation expense related to purchase rights under the ESPP but not yet recognized was approximately $223,000. This expense will be amortized on a straight-line basis over a weighted average period of approximately 1.1 years.

 

Valuation Assumptions

 

    Valuation and Amortization Method. The Company estimates the fair value of stock options granted using the Black-Scholes option valuation model and a single option award approach. The fair value under the single option approach is amortized on a straight-line basis over the requisite service periods of the awards, which is generally the vesting period.

 

    Expected Term. The Company’s expected term represents the period that the Company’s stock-based awards are expected to be outstanding and was determined based on historical experience, giving consideration to the contractual terms of the stock-based awards, vesting schedules and expectations of future employee behavior as evidenced by changes to the terms of its stock-based awards.

 

    Volatility. Volatility is a measure of the amounts by which a financial variable such as stock price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company uses the historical volatility for the past four or five years, which matches the expected term of most of the option grants, to estimate expected volatility. Volatility for each of the ESPP’s four time periods of six months, twelve months, eighteen months, and twenty-four months is calculated separately and included in the overall stock-based compensation expense recorded.

 

    Risk-Free Interest Rate. The Company bases the risk-free interest rate used in the Black-Scholes option valuation model on the implied yield in effect at the time of option grant on U.S. Treasury zero-coupon issues with a remaining term equivalent to the expected term of the stock awards including the ESPP.

 

    Fair Value. The fair value of the Company’s stock options granted to employees for the three months ended August 31, 2018 and 2017 were estimated using the following weighted average assumptions in the Black-Scholes option valuation model:

 

    Three Months Ended  
    August 31,  
    2018     2017  
             
Expected term (in years)     5       4  
Volatility     0.74       0.78  
Risk-free interest rate     2.75 %     1.75 %
Weighted average grant date fair value   $ 1.48     $ 2.27  

 

    There were no ESPP purchase rights granted to employees for the three months ended August 31, 2018 and 2017. There were no ESPP shares issued during the three months ended August 31, 2018 and 2017. As of August 31, 2018, there were 145,000 ESPP shares available for issuance.

 

    The following tables summarize the Company’s stock option and RSU transactions during three months ended August 31, 2018 (in thousands):

 

    Available  
    Shares  
Balance, May 31, 2018     1,812  
         
  Options granted     (441 )
  RSUs granted     --  
  Shares cancelled     13  
  Shares expired     (11 )
         
Balance, August 31, 2018     1,373  

 

    The following table summarizes the stock option transactions during the three months ended August 31, 2018 (in thousands, except per share data):

 

    Outstanding Options  
          Weighted        
    Number     Average     Aggregate  
    of     Exercise     Intrinsic  
    Shares     Price     Value  
Balances, May 31, 2018     2,859     $ 2.04     $ 1,987  
                         
Options granted     441     $ 2.40          
Options cancelled     (13 )   $ 1.64          
Options exercised     (98 )   $ 1.12          
                         
Balances, August 31, 2018     3,189     $ 2.12     $ 1,757  
                         
Options fully vested and expected to vest at August 31, 2018     3,156     $ 2.12     $ 1,746  

 

    The options outstanding and exercisable at August 31, 2018 were in the following exercise price ranges (in thousands, except per share data):

 

        Options Outstanding     Options Exercisable
        at August 31, 2018     at August 31, 2018
 

Range of Exercise

Prices

    Number Outstanding Shares     Weighted Average Remaining Contractual Life (Years)     Weighted Average Exercise Price     Number Exercisable Shares     Weighted Average Remaining Contractual Life (Years)     Weighted Average Exercise Price  

Aggregate Intrinsic Value

   
  $ 0.59-$0.97       259       0.51     $ 0.67       259       0.51     $ 0.67        
  $ 1.09-$1.36       507       1.46     $ 1.28       506       1.46     $ 1.28        
  $ 1.68-$2.06       466       4.04     $ 1.74       318       3.64     $ 1.77        
  $ 2.10-$2.81       1,695       4.34     $ 2.44       1,130       3.26     $ 2.47        
  $ 3.46-$3.93       262       5.91     $ 3.86       94       5.96     $ 3.76        
  $ 0.59-$3.93       3,189       3.66     $ 2.12       2,307       2.72     $ 1.96     $1,541    

 

    The total intrinsic value of options exercised during the three months ended August 31, 2018 and 2017 was $139,000 and $476,000, respectively. The weighted average remaining contractual life of the options exercisable and expected to be exercisable at August 31, 2018 was 3.64 years.

 

    During the three months ended August 31, 2018, there were no RSUs granted to employees. During the three months ended August 31, 2017, RSUs for 64,000 shares were granted to employees. The market value on the date of the grant of these RSUs was $3.93 per share. 2,000 RSUs became fully vested during the three months ended August 31, 2017, and 93,000 RSUs were unvested at August 31, 2017. During the three months ended August 31, 2018, 4,000 RSUs became fully vested. As of August 31, 2018, 43,000 RSUs remain unvested which have an intrinsic value of $108,000.